Pharmaceutical Product Development Inc (PPDI) Bond Prices Fall 1.1%
An issue of Pharmaceutical Product Development Inc (NASDAQ:PPDI) debt fell 1.1% as a percentage of its face value during trading on Friday. The high-yield debt issue has a 6.375% coupon and will mature on August 1, 2023. The bonds in the issue are now trading at $104.50 and were trading at $104.75 one week ago. Price changes in a company’s debt in credit markets often predict parallel changes in its share price.
About Pharmaceutical Product Development
Pharmaceutical Product Development, Inc is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services.
Receive News & Stock Ratings for Pharmaceutical Product Development Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmaceutical Product Development Inc and related stocks with our FREE daily email newsletter.